Projects

EPI-HPV-UV-CA

project name: Epidemiology of Human papillomavirus (HPV) infection, ultraviolet (UV) radiation in relation to non-melanoma skin cancer

initiating country: The European Union

Framework Programme: FP5       programme area: QoL – Quality of Life and Management of Living Resources

contract/proposal/call number: QLK2-CT-2001-01179

status: completed

start date: September 2002       duration: 36 months       projected finish date: September 2005

Project Budget

total budget: € 1,740,000

Participants

Note that the follow people may not represent the full extent of the consortium. FEAST has tried to identify the Australian participants, and their collaborators (or coordinator), within the project. Also note that Australian participation may not necessarily be on a formal level.

nameorganisationstate or country
Prof Adele GreenQIMR QLD, Australia

Further information

summary:

Non-melanoma skin cancers (squamous cell and basal cell carcinoma) are the most frequent malignant tumors of man. The etiology of skin cancer is still under debate. Recent reports demonstrated a high prevalence of human-papillomovirus (HPV)-DNA in non-melanoma skin cancers. The etiologic role of some HPV types in the development of cervical cancer is well established. HPV types probably also play a role in head and neck cancers. The identification of HPV in skin cancer may indicate a similar key role in the pathogenesis of skin tumors, which would raise prospects of prevention by vaccination and provide targets for therapeutic options. This proposal is the first unified initiative of nine European institutions in Northern and Southern Europe and one in Australia, each disposing of a long-standing expertise in the field of papillomavirus research and/or epidemiology of skin cancer to study the role of HPV in skin cancer oncogenesis.

Project coordinator:

Dr Jan Nico BOUWES BAVINCK
Department of Dermatology
Leiden University Medical Centre
PO Box 9600
2300 RC Leiden NETHERLANDS
Tel: +31 (71) 526 2421
Fax: +31 (71) 524 8106
Email: J.N.Bouwes_Bavinck@lumc.nl

Participants:

Participant name

Status*

Country

Leiden University Medical Centre

C

Netherlands

Queensland Institute of Medical Research

M

Australia

Université Claude Bernard Lyon 1

M

France

German Cancer Research Centre

M

Germany

Humboldt-Universität Berlin

M

Germany

Institut für Virologie

M

Germany

Azienda Ospedaliera Ospedali Ruiniti di Bergamo
M
Italy
Provincia Italiana della Congregazione dei Figli dell’immacolata Concezione - Istituto Dermopatico dell’immacolata
M
Italy
Delft Diagnostic Laboratory B.V.
M
Netherlands
University of London
M
United Kingdom

*C = Co-ordinator; M = Member

Sources: European Commission